JUPITER, Fla. (AP) — JUPITER, Fla. (AP) — Ligand Pharmaceuticals Inc. (LGND) on Thursday reported fourth-quarter earnings of $44.8 million.
On a per-share basis, the Jupiter, Florida-based company said it had net income of $2.12. Earnings, adjusted for non-recurring gains, were $2.02 per share.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.46 per share.
The drugmaker posted revenue of $59.7 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $58.2 million.
For the year, the company reported profit of $124.5 million, or $6.13 per share. Revenue was reported as $268.1 million.
Ligand expects full-year earnings in the range of $8 to $9 per share, with revenue in the range of $245 million to $285 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LGND at https://www.zacks.com/ap/LGND
/Tesla%20Inc%20logo%20by-%20baileystock%20via%20iStock.jpg)
/Nvidia%20logo%20and%20sign%20on%20headquarters%20by%20Michael%20Vi%20via%20Shutterstock.jpg)
